Rowan Hardy

1 - 10 out of 36Page size: 10

Publications

  1. 2020
  2. Published

    Therapeutic glucocorticoids mechanisms of actions in rheumatic diseases

    Karim Raza, Rowan Hardy, Mar 2020, In : Nature Reviews Rheumatology. 16, 3, p. 133-144 12 p.

    Research output: Contribution to journal › Review article

  3. 2019
  4. Published

    Exploring the interface between inflammatory and therapeutic glucocorticoid induced bone and muscle loss

    Rowan Hardy, 16 Nov 2019, In : International Journal of Molecular Sciences. 20, 22, 22 p., 5768.

    Research output: Contribution to journal › Article

  5. Published

    11β-HSD1 Plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy

    Craig Doig, Amy Naylor, Christopher Buckley, Gareth Lavery, Karim Raza & Rowan Hardy, 16 Aug 2019, In : Arthritis Research & Therapy. 21, 1, 188.

    Research output: Contribution to journal › Article

  6. Published

    Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis

    Rebecca Jones, Yu-Chiang Lai, Simon Jones, Gareth Lavery, Karim Raza & Rowan Hardy, 1 Aug 2019, In : Arthritis Research & Therapy. 21, 1, 182.

    Research output: Contribution to journal › Article

  7. Published

    Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study

    Michael Sagmeister, Angela Taylor, Nadya Wall, Dimitri Chanouzas, Wiebke Arlt, Rowan Hardy, Jan 2019, In : Clinical Endocrinology. 90, 1, p. 241-249 9 p.

    Research output: Contribution to journal › Article

  8. 2018
  9. Published

    Unravelling how glucocorticoids work in rheumatoid arthritis

    Rowan Hardy, 4 Sep 2018, In : Nature Reviews Rheumatology. p. 1759-4804 2 p.

    Research output: Contribution to journal › Article

  10. Published

    11beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis

    Rowan Hardy, Adam Croft, Amy Naylor, Guillaume Desanti, Christopher Buckley, Gareth Lavery & Karim Raza, 1 Aug 2018, In : Journal of Autoimmunity. 92, p. 104-113 10 p.

    Research output: Contribution to journal › Article

  11. Published

    Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy

    Rowan Hardy, 13 Jun 2018, In : Endocrine Reviews. er.2018-00097.

    Research output: Contribution to journal › Article

  12. 2017
  13. Published

    Cerebral Oxidative Stress and Microvasculature Defects in TNF-α Expressing Transgenic and Porphyromonas gingivalis-Infected ApoE-/- Mice

    Rowan Hardy, 18 Sep 2017, In : Journal of Alzheimer's Disease. 60, 2, p. 359-369 10 p.

    Research output: Contribution to journal › Article

  14. E-pub ahead of print

    TNFα depleting therapy improves fertility and animal welfare in TNFα-driven transgenic models of polyarthritis when administered in their routine breeding

    Amy Naylor, Guillaume Desanti, Atif Saghir & Rowan Hardy, 8 May 2017, In : Laboratory Animals.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 Next